What is the Future of Synthetic Lethality in Cancer Research?
The future of synthetic lethality in cancer research looks promising with advances in genomics, bioinformatics, and drug development. Large-scale projects like the Cancer Genome Atlas provide comprehensive data that can be mined for potential synthetic lethal interactions. Improved computational models and machine learning algorithms are enhancing the prediction of these interactions. Additionally, new technologies like CRISPR are revolutionizing the validation and discovery processes.
